ciprofloxacin has been researched along with Fever of Unknown Origin in 19 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Fever of Unknown Origin: Fever in which the etiology cannot be ascertained.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 9.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "To compare the efficacy and safety of ciprofloxacin (CIP) and trimethoprim/sulfamethoxazole (TMS) for the prevention of bacterial infections in patients who received bone marrow transplantation (BMT) for the treatment of solid and hematopoietic neoplasms." | 9.08 | Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. ( Antman, KH; Finberg, R; Kalish, LA; Kehoe, K; Lew, MA; Nadler, L; Ritz, J, 1995) |
| "Retrospective evaluation of Tc-99m ciprofloxacin (infection) scintigraphy consecutively performed in a series of patients clinically suspected for peripheral osteomyelitis (OM), spondylodiscitis (SD) and fever of unknown origin (FUO)." | 7.71 | [Tc-99m ciprofloxacin in clinically selected patients for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin--preliminary results]. ( Gallowitsch, HJ; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P, 2002) |
| "In hospitalized low-risk patients who have fever and neutropenia during cancer chemotherapy, empirical therapy with oral ciprofloxacin and amoxicillin-clavulanate is safe and effective." | 5.09 | A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. ( Chanock, S; Freifeld, A; Gill, V; Hicks, JE; Hiemenz, J; Hiemenz, S; Lewis, L; Marchigiani, D; Pizzo, PA; Steinberg, SM; Walsh, T, 1999) |
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 5.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "To compare the efficacy and safety of ciprofloxacin (CIP) and trimethoprim/sulfamethoxazole (TMS) for the prevention of bacterial infections in patients who received bone marrow transplantation (BMT) for the treatment of solid and hematopoietic neoplasms." | 5.08 | Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. ( Antman, KH; Finberg, R; Kalish, LA; Kehoe, K; Lew, MA; Nadler, L; Ritz, J, 1995) |
| "Retrospective evaluation of Tc-99m ciprofloxacin (infection) scintigraphy consecutively performed in a series of patients clinically suspected for peripheral osteomyelitis (OM), spondylodiscitis (SD) and fever of unknown origin (FUO)." | 3.71 | [Tc-99m ciprofloxacin in clinically selected patients for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin--preliminary results]. ( Gallowitsch, HJ; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P, 2002) |
| "The diagnosis of Q fever should be considered in cases of fever of unknown origin, especially if the subject has been in contact with mammals suspicious to be infected." | 2.46 | [Infection by Coxiella burnetii (Q fever)]. ( Collado, CM; Fariñas, MT, 2010) |
| "Typhoid fever is an acute infectious disease caused by Salmonella serotype Typhi, leading to endemic or epidemic outbreaks in tropical/ subtropical countries (especially in India, Southeast Asia, Central and South Africa)." | 1.33 | [A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection]. ( Akin, K; Cesur, S; Esen, B; Levent, B; Willke, A; Yavuzdemir, S, 2005) |
| "We report a case of agranulocytosis which developed 3 weeks after onset of acute hepatitis B in an HIV-positive patient." | 1.31 | [Agranulocytosis in acute hepatitis B in an HIV seropositive patient]. ( Brazille, P; Coutant-Perronne, V; Malkin, JE; Raguin, G, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Oliver, AC | 1 |
| Riva, E | 1 |
| Mosquera, R | 1 |
| Galeano, S | 1 |
| Pierri, S | 1 |
| Bello, L | 1 |
| Caneiro, A | 1 |
| Gai, R | 1 |
| Miller, A | 1 |
| Muxi, P | 1 |
| Saxena, S | 1 |
| Dwivedi, M | 1 |
| Batra, P | 1 |
| Dutta, R | 1 |
| Fariñas, MT | 1 |
| Collado, CM | 1 |
| Kreft, B | 1 |
| Oehme, A | 1 |
| Lübbert, C | 1 |
| Marsch, WC | 1 |
| Kekulé, AS | 1 |
| Harangi, M | 1 |
| Kovács, T | 1 |
| Rákóczi, É | 1 |
| Rejto, L | 1 |
| Mikó, L | 1 |
| Tóth, L | 1 |
| Szucs, G | 1 |
| Galuska, L | 1 |
| Paragh, G | 1 |
| Sohn, BS | 1 |
| Yoon, DH | 1 |
| Kim, S | 1 |
| Lee, K | 1 |
| Kang, EH | 1 |
| Park, JS | 1 |
| Lee, DH | 1 |
| Kim, SH | 1 |
| Huh, J | 1 |
| Suh, C | 1 |
| Gemmel, F | 1 |
| Hamerlynck, N | 1 |
| Vanderschueren, G | 1 |
| Giri, M | 1 |
| Goethals, I | 1 |
| Jacobs, F | 1 |
| Zimmermann, O | 1 |
| de Ciman, R | 1 |
| Gross, U | 1 |
| Akin, K | 1 |
| Yavuzdemir, S | 1 |
| Cesur, S | 1 |
| Levent, B | 1 |
| Esen, B | 1 |
| Willke, A | 1 |
| Velasco, E | 1 |
| Costa, MA | 1 |
| Martins, CA | 1 |
| Nucci, M | 1 |
| Lew, MA | 1 |
| Kehoe, K | 1 |
| Ritz, J | 1 |
| Antman, KH | 1 |
| Nadler, L | 1 |
| Kalish, LA | 1 |
| Finberg, R | 1 |
| Cornelissen, JJ | 1 |
| Rozenberg-Arska, M | 1 |
| Dekker, AW | 1 |
| Freifeld, A | 2 |
| Pizzo, P | 1 |
| Marchigiani, D | 1 |
| Walsh, T | 1 |
| Chanock, S | 1 |
| Lewis, L | 1 |
| Hiemenz, J | 1 |
| Hiemenz, S | 1 |
| Hicks, JE | 1 |
| Gill, V | 1 |
| Steinberg, SM | 1 |
| Pizzo, PA | 1 |
| Antabli, BA | 1 |
| Bross, P | 1 |
| Siegel, RS | 1 |
| Small, CD | 1 |
| Tabbara, IA | 1 |
| Brazille, P | 1 |
| Coutant-Perronne, V | 1 |
| Malkin, JE | 1 |
| Raguin, G | 1 |
| Paganini, H | 1 |
| Rodriguez-Brieshcke, T | 1 |
| Zubizarreta, P | 1 |
| Latella, A | 1 |
| Firpo, V | 1 |
| Casimir, L | 1 |
| Armada, A | 1 |
| Fernández, C | 1 |
| Cáceres, E | 1 |
| Debbag, R | 1 |
| Gallowitsch, HJ | 1 |
| Heinisch, M | 1 |
| Mikosch, P | 1 |
| Kresnik, E | 1 |
| Kumnig, G | 1 |
| Gomez, I | 1 |
| Lind, P | 1 |
| De Pauw, BE | 1 |
| Donnelly, JP | 1 |
| De Witte, T | 1 |
| Nováková, IR | 1 |
| Schattenberg, A | 1 |
1 review available for ciprofloxacin and Fever of Unknown Origin
| Article | Year |
|---|---|
[Infection by Coxiella burnetii (Q fever)].
Topics: Animals; Animals, Domestic; Antibodies, Bacterial; Ciprofloxacin; Coxiella burnetii; DNA, Bacterial; | 2010 |
7 trials available for ciprofloxacin and Fever of Unknown Origin
| Article | Year |
|---|---|
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Ana | 1995 |
Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
Topics: Administration, Oral; Adult; Bacterial Infections; Bone Marrow Transplantation; Cause of Death; Cipr | 1995 |
Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fever of Unknown | 1995 |
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Ag | 1999 |
Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; C | 1999 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineopla | 2001 |
Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
Topics: Adult; Bacterial Infections; Bone Marrow Transplantation; Chi-Square Distribution; Ciprofloxacin; Cl | 1990 |
11 other studies available for ciprofloxacin and Fever of Unknown Origin
| Article | Year |
|---|---|
Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Topics: Adolescent; Adult; Aged; Amikacin; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Prot | 2020 |
Fever of unknown origin attributable to haematocolpos infected with Salmonella enterica Serotypetyphi resistant to nalidixic acid: a case report.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child; Ciprofloxacin; Diagnosis, Differen | 2013 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal | 2010 |
Malignancy or inflammation? A case report of a young man with fever of unknown origin.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Fever of Unknown Origin; Humans; Male; | 2011 |
The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience.
Topics: Acyclovir; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Chem | 2012 |
Multimodality SPECT imaging of multifocal spondylodiscitis.
Topics: Aged; Back Pain; Ciprofloxacin; Discitis; Female; Fever of Unknown Origin; Humans; Lumbar Vertebrae; | 2004 |
Bacteremia among Kenyan Children.
Topics: Bacteremia; Cephalosporins; Ciprofloxacin; Fever of Unknown Origin; Ghana; Humans; Microbial Sensiti | 2005 |
[A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection].
Topics: Adult; Afghanistan; Agglutination Tests; Anti-Infective Agents; Antibodies, Bacterial; Ciprofloxacin | 2005 |
Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients.
Topics: Administration, Oral; Anti-Infective Agents; Child; Ciprofloxacin; Fever of Unknown Origin; Humans; | 1997 |
[Agranulocytosis in acute hepatitis B in an HIV seropositive patient].
Topics: Acute Disease; Adult; Agranulocytosis; Anti-HIV Agents; Ciprofloxacin; Diagnosis, Differential; Drug | 2000 |
[Tc-99m ciprofloxacin in clinically selected patients for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin--preliminary results].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone and Bones; Ciprofloxacin; Diagnosis, Diff | 2002 |